Switch to:
Also traded in: Brazil, France, Germany, Luxembourg, Mexico, Netherlands, Spain, Switzerland, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.18
NYSE:MT's Cash-to-Debt is ranked lower than
70% of the 545 Companies
in the Global Steel industry.

( Industry Median: 0.55 vs. NYSE:MT: 0.18 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:MT' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.2 Max: 1.26
Current: 0.18
0.03
1.26
Equity-to-Asset 0.40
NYSE:MT's Equity-to-Asset is ranked lower than
58% of the 532 Companies
in the Global Steel industry.

( Industry Median: 0.46 vs. NYSE:MT: 0.40 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:MT' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.02  Med: 0.38 Max: 0.48
Current: 0.4
0.02
0.48
Interest Coverage 2.58
NYSE:MT's Interest Coverage is ranked lower than
73% of the 425 Companies
in the Global Steel industry.

( Industry Median: 9.37 vs. NYSE:MT: 2.58 )
Ranked among companies with meaningful Interest Coverage only.
NYSE:MT' s Interest Coverage Range Over the Past 10 Years
Min: 0.63  Med: 1.94 Max: 8.06
Current: 2.58
0.63
8.06
Altman Z-Score: 1.60
WACC vs ROIC
9.93%
8.57%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating Margin % 7.29
NYSE:MT's Operating Margin % is ranked higher than
76% of the 542 Companies
in the Global Steel industry.

( Industry Median: 2.56 vs. NYSE:MT: 7.29 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:MT' s Operating Margin % Range Over the Past 10 Years
Min: -6.54  Med: 4.23 Max: 14.09
Current: 7.29
-6.54
14.09
Net Margin % 3.12
NYSE:MT's Net Margin % is ranked higher than
62% of the 544 Companies
in the Global Steel industry.

( Industry Median: 1.49 vs. NYSE:MT: 3.12 )
Ranked among companies with meaningful Net Margin % only.
NYSE:MT' s Net Margin % Range Over the Past 10 Years
Min: -12.5  Med: 1.42 Max: 9.85
Current: 3.12
-12.5
9.85
ROE % 7.63
NYSE:MT's ROE % is ranked higher than
70% of the 520 Companies
in the Global Steel industry.

( Industry Median: 3.58 vs. NYSE:MT: 7.63 )
Ranked among companies with meaningful ROE % only.
NYSE:MT' s ROE % Range Over the Past 10 Years
Min: -25.45  Med: 2.24 Max: 20.11
Current: 7.63
-25.45
20.11
ROA % 2.93
NYSE:MT's ROA % is ranked higher than
63% of the 550 Companies
in the Global Steel industry.

( Industry Median: 1.57 vs. NYSE:MT: 2.93 )
Ranked among companies with meaningful ROA % only.
NYSE:MT' s ROA % Range Over the Past 10 Years
Min: -9.66  Med: 1.02 Max: 8.04
Current: 2.93
-9.66
8.04
ROC (Joel Greenblatt) % 12.00
NYSE:MT's ROC (Joel Greenblatt) % is ranked higher than
70% of the 548 Companies
in the Global Steel industry.

( Industry Median: 6.36 vs. NYSE:MT: 12.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:MT' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -14.56  Med: 4.16 Max: 21.89
Current: 12
-14.56
21.89
3-Year Revenue Growth Rate -10.10
NYSE:MT's 3-Year Revenue Growth Rate is ranked lower than
65% of the 497 Companies
in the Global Steel industry.

( Industry Median: -5.40 vs. NYSE:MT: -10.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:MT' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -36.6  Med: -4.1 Max: 55.3
Current: -10.1
-36.6
55.3
3-Year EBITDA Growth Rate 16.70
NYSE:MT's 3-Year EBITDA Growth Rate is ranked higher than
71% of the 387 Companies
in the Global Steel industry.

( Industry Median: 3.20 vs. NYSE:MT: 16.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:MT' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -55.4  Med: -2.95 Max: 187.2
Current: 16.7
-55.4
187.2
GuruFocus has detected 3 Warning Signs with ArcelorMittal SA $NYSE:MT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:MT's 10-Y Financials

Financials (Next Earnings Date: 2017-05-12)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MT Guru Trades in Q1 2016

Jim Simons 5,567,420 sh (+88.02%)
» More
Q2 2016

MT Guru Trades in Q2 2016

Paul Tudor Jones 21,298 sh (New)
Jim Simons 12,992,409 sh (+133.36%)
» More
Q3 2016

MT Guru Trades in Q3 2016

Sarah Ketterer 1,475,251 sh (New)
Paul Tudor Jones Sold Out
Jim Simons 6,964,231 sh (-46.40%)
» More
Q4 2016

MT Guru Trades in Q4 2016

David Tepper 976,578 sh (New)
Steven Cohen 410,900 sh (New)
Sarah Ketterer 877,287 sh (-40.53%)
Jim Simons 1,157,679 sh (-83.38%)
» More
» Details

Insider Trades

Latest Guru Trades with MT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Steel » Steel    NAICS: 331110 
Compare:NYSE:PKX, OTCPK:NSSMY, NYSE:TS, NYSE:NUE, OTCPK:TKAMY, OTCPK:FOSUY, OTCPK:CISXF, OTCPK:SVJTY, NAS:STLD, OTCPK:CTPCY, OTCPK:VLPNY, OTCPK:HMTLY, NYSE:X, NYSE:GGB, NYSE:RS, NYSE:TX, OTCPK:ANGGY, OTCPK:BLSFY, OTCPK:SSAAY, OTCPK:OUTFF » details
Traded in other countries:ARMT34.Brazil, MT.France, ARRB.Germany, NSCLU3134005.Luxembourg, MTN.Mexico, MT.Netherlands, MTS.Spain, MT.Switzerland, AMSYF.USA,
Headquarter Location:Luxembourg
ArcelorMittal SA is a steel and mining company. The Company produces flat products, including sheet and plate, and long products, including bars, rods and structural shapes.

ArcelorMittal is the largest player in the global steel industry. Formed in 2006 via the merger of Arcelor and Mittal Steel, the two largest steelmakers at the time, ArcelorMittal now produces roughly 6% of the world's steel. The company derives the majority of its revenue from North America and Europe, while emerging markets account for approximately 40% of the company's total sales.

Top Ranked Articles about ArcelorMittal SA

Mettrum Announces Fourth Quarter and Full Fiscal Year 2016 Financial Results

TORONTO, ONTARIO--(Marketwired - Jun 29, 2016) - Q4 2016 versus Q3 Financial Highlights:

Revenues increased 35% to $2,714,468
Grams sold increased 32% to 305,950 grams
Gross Margin increased 47% to $1,993,109
Adjusted EDITDA loss improved by 38% to a loss of $823,066
Registered clients increased by 44% to 7,200 (as at June 29, 2016 - 12,000, a 67% increase since March 31, 2016)





Mettrum Health Corp. ("Mettrum" or the "Company") (TSX VENTURE:MT), a fully integrated provider of cannabis products, announced today its fourth quarter and full fiscal year 2016 financial results for the period ended March 31, 2016.





















Figures in

CDN $

For the three months

ended Mar 31, 2016


For the three months

ended Dec 31, 2015


For the three months

ended Mar 31, 2015



For the year ended Mar 31, 2016


For the year ended Mar 31, 2015



Grams and Gram equivalents sold

305,950


230,995


115,065



909,235


418,372



Revenue

2,714,468


2,016,863


847,690



7,691,574


3,058,711



Gross profit

1,993,109


1,351,286


571,850



5,001,756


1,297,567



Operating expenses

3,372,309


3,244,850


2,421,909



12,313,959


7,508,814



Adjusted EBITDA

(823,066
)

(1,337,989
)

(1,424,683
)


(5,395,037
)

(5,374,657
)


Loss from operations

(1,379,200
)

(1,893,564
)

(1,850,059
)


(7,312,203
)

(6,211,247
)


Net loss

(1,421,201
)

(1,882,451
)

(1,795,416
)


(7,298,962
)

(7,035,936
)


Net loss per share basic and diluted



(0.04
)



(0.06
)



(0.05
)




(0.22
)



(0.27
)






















Operating Highlights

Mettrum is currently licensed to produce and sell dried cannabis and cannabis extracts from each of its three facilities which, on a combined basis, are approximately 90,000 square feet. Mettrum is currently licensed to produce 3,550 kgs of dried cannabis annually and has current available production capacity of up to 6,000 kgs annually. On a fully built out basis, which is expected by the end of the year, Mettrum's, total production capacity will increase to up to 12,000 kgs annually Mettrum Originals entered into a three-year partnership with Live Nation to name Toronto's Molson Canadian Amphitheatre's grass seating area "The Mettrum Originals Lawn", and including the right to sample and sell Mettrum Originals' products at the venue. Mettrum Originals products are now sold at over 2,000 retailers in Canada and the United States. Mettrum has entered into a supply and services agreement with Agriculture Victoria (Department of Economic Development, Jobs, Transport and Resources), on behalf of the Victorian Government in Australia. Mettrum has received an export permit from Health Canada to export starter material and has subsequently shipped that material and will provide advisory and consulting services to Agriculture Victoria. This arrangement is for the cannabis horticultural research trial being undertaken by Agriculture Victoria.





Fourth Quarter ended March 31, 2016 Review

Revenues increased 35% to $2,714,468 versus $2,016,863 during the third quarter ended December 31, 2015. Average selling price per gram increased to $8.23 during the fourth quarter ended March 31, 2016 from $7.90 during the third quarter ended December 31, 2015. Gross margin increased by 47% to $1,993,109 or 73% of sales, from $1,351,286 or 67% of sales during the third fourth quarter. Growing costs were reduced by 2% to $2.49 per gram for the quarter ended March 31, 2016 from $2.55 for the third quarter ended December 31, 2015. Adjusted EBITDA loss significantly improved by 38% to a loss of $823,066 for the quarter ended March 31, 2016 versus a loss of $1,337,989 for the third quarter ended December 31, 2015. As at March 31, 2016, Mettrum's registered client count increased to 7,200, representing a 44% increase over December 31, 2015. As at the date of this report, Mettrum is serving the needs of approximately 12,000 registered clients, representing a 67% increase in customer registration from March 31, 2016 to date.





To view the Quarterly Sales graph, please click on the following link: http://media3.marketwire.com/docs/QuarterlySales.jpg To view the Quarterly Clients graph, please click on the following link: http://media3.marketwire.com/docs/QuarterlyClients.jpg Fiscal Year ended March 31, 2016 Review

Revenues increased 151% to $7,691,574 versus $3,058,711 during the previous year. Average selling price per gram increased to $7.87 from $7.31 during fiscal 2016. Gross margin increased by 285% to $5,001,756 or 65% or sales, from $1,297,567 or 42 % of sales during fiscal 2016. Adjusted EBITDA loss amounted to a loss of $5,395,037 for the full year ended March 31, 2016 versus a loss of $5,374,657 in fiscal 2015.





As at March 31, 2016, the Company maintained a solid balance sheet with a net cash position of approximately $7.1 million. Subsequently, Mettrum completed a financing on May 10, 2016 for $7.8 million of net proceeds. "I am very pleased with our performance over the past year. The final quarter capped off a year of continuously improving growth in revenue and operating margins. We're looking forward to further success during the coming year," noted Michael Haines, CEO of Mettrum. "Fiscal 2017 is off to a strong start. With all three of our facilities licensed for production and sale of dried cannabis and cannabis extracts, we will continue to grow the business and achieve cash flow break even while maintaining market share. Mettrum will continue to build upon our physician centric medical business and due to our current and future production capacity, and operational expertise, the company is exceptionally well positioned to be a major player when the recreational market opens up in Canada. It is our goal to launch our first retail oriented products within the year." About Mettrum Health Corp. Mettrum Health Corp. is a Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the MMPR, which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its Mettrum Creemore facility in Clearview, Ontario. Mettrum received its third license from Health Canada under the MMPR on December 17, 2015 for its new 60,000 square foot production and distribution facility in Bowmanville, Ontario. With the Company's three licenses, Mettrum is a leading producer and vendor of medical cannabis under the MMPR system. In addition, through its wholly owned subsidiary Mettrum Hempworks, Mettrum also is a licensed producer and distribution of industrial cannabis (hemp) products, including Mettrum's functional food line, Mettrum Originals, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada). For more information, visit: www.mettrumoriginals.com and www.mettrum.com CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company and Mettrum disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.





Mettrum Health Corp.
Ali Mahdavi
Director, Investor Relations
416.962.3300
[email protected]
www.mettrum.com




Read more...
Mettrum Announces Fourth Quarter and Full Fiscal Year 2016 Financial Results Notification

TORONTO, ONTARIO--(Marketwired - Jun 22, 2016) - Mettrum Health Corp. ("Mettrum" or the "Company") (TSX VENTURE:MT), a fully integrated provider of cannabis products, is pleased to announce that it will report its fourth quarter and full fiscal year 2016 financial results for the period ended March 31, 2016, on June 29, 2016 after the close of market. About Mettrum Health Corp. Mettrum Health Corp. is a Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the MMPR, which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its Mettrum Creemore facility in Clearview, Ontario. Mettrum received its third license from Health Canada under the MMPR on December 17, 2015 for its new 60,000 square foot production and distribution facility in Bowmanville, Ontario. With the Company's three licenses, Mettrum is a leading producer and vendor of medical cannabis under the MMPR system. In addition, through its wholly owned subsidiary Mettrum Hempworks, Mettrum also is a licensed producer and distribution of industrial cannabis (hemp) products, including Mettrum's functional food line, Mettrum Originals, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada). For more information, visit: www.mettrumoriginals.com and www.mettrum.com. Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.





Mettrum Health Corp.
Ali Mahdavi
Director, Investor Relations
416.962.3300
[email protected]
www.mettrumoriginals.com / www.mettrum.com




Read more...
Mettrum Receives License Amendment for the Sale of Medical Cannabis and Extracts at its 60,000 Square Foot Facility in Bowmanville

TORONTO, ONTARIO--(Marketwired - May 9, 2016) - Mettrum Health Corp. ("Mettrum" or the "Company") (TSX VENTURE:MT), a fully integrated provider of cannabis products, is pleased to announce that the Company has received an amendment to its license to include both the production and sale of medical cannabis and extracts from Health Canada under the Marihuana for Medical Purposes Regulations (Canada) ("MMPR") at its 60,000 square foot production and distribution facility located in Bowmanville, Ontario ("Bowmanville South"). Under the MMPR, the license was upgraded from production only and provides Mettrum with the ability to produce and sell dried medical cannabis as well as cannabis extracts from the Bowmanville South facility. This provides the company with total licensed production capacity of 3,500 kg and licensed sales capacity of 3,550 kg of dried cannabis and production and sales capacity of 1,906 kg of cannabis extracts. The Bowmanville South facility has total production capacity on a fully built out basis of 8,000 kg of cannabis representing $60 million in sales plus potential extracts. "This latest milestone is significant as we can now transition our distribution hub from our original facility at Bennett Road North, to our largest facility down the road. We continue to advance our business plan," said Michael Haines, CEO of Mettrum. "These latest amendments will contribute to our continually improving operational efficiency and margins." Mettrum has three fully licensed facilities to produce and sell dried cannabis and cannabis extracts, with a production capacity on a fully built out basis of 12,000 kg per year. As one of Canada's largest producers and sellers of medical cannabis, Mettrum is exceptionally well-positioned to serve the needs of a growing and regulated market. About Mettrum Health Corp Mettrum Health Corp. is a Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., a wholly owned subsidiary of the Company, is a Toronto-based company and a licensed producer of medical cannabis under the MMPR, which came into effect on October 1, 2013. Mettrum received its first license from Health Canada under the MMPR on November 1, 2013 and began production of medical cannabis at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada under the MMPR on December 11, 2014 for its Mettrum Creemore facility in Clearview, Ontario. Mettrum received its third license from Health Canada under the MMPR on December 17, 2015 for its new 60,000 square foot production and distribution facility in Bowmanville, Ontario. With the Company's three licenses, Mettrum is a leading producer and vendor of medical cannabis under the MMPR system. In addition, through its wholly owned subsidiary Mettrum Hempworks, Mettrum also is a licensed producer and distribution of industrial cannabis (hemp) products, including Mettrum's functional food line, Mettrum Originals, under the Industrial Hemp Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act (Canada). For more information, visit: www.mettrumoriginals.com and www.mettrum.com CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation, including, without limitation, the anticipated legalization of marijuana, the nature of the legalized and regulatory regime, the scope and functioning of the recreational and retail markets, as well as the Company's capacity, strategy and participation in any such market. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors, which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this press release.





Mettrum Health Corp.
Ali Mahdavi
Director, Investor Relations
416.962.3300
[email protected]




Read more...

Ratios

vs
industry
vs
history
PE Ratio 13.55
MT's PE Ratio is ranked higher than
60% of the 363 Companies
in the Global Steel industry.

( Industry Median: 15.53 vs. MT: 13.55 )
Ranked among companies with meaningful PE Ratio only.
MT' s PE Ratio Range Over the Past 10 Years
Min: 1.83  Med: 12.63 Max: 45.27
Current: 13.55
1.83
45.27
Forward PE Ratio 9.90
MT's Forward PE Ratio is ranked higher than
93% of the 97 Companies
in the Global Steel industry.

( Industry Median: 14.47 vs. MT: 9.90 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 13.55
MT's PE Ratio without NRI is ranked higher than
61% of the 360 Companies
in the Global Steel industry.

( Industry Median: 15.67 vs. MT: 13.55 )
Ranked among companies with meaningful PE Ratio without NRI only.
MT' s PE Ratio without NRI Range Over the Past 10 Years
Min: 1.83  Med: 11.13 Max: 38.7
Current: 13.55
1.83
38.7
PB Ratio 0.85
MT's PB Ratio is ranked higher than
59% of the 515 Companies
in the Global Steel industry.

( Industry Median: 1.02 vs. MT: 0.85 )
Ranked among companies with meaningful PB Ratio only.
MT' s PB Ratio Range Over the Past 10 Years
Min: 0.25  Med: 0.56 Max: 2.01
Current: 0.85
0.25
2.01
PS Ratio 0.39
MT's PS Ratio is ranked higher than
65% of the 536 Companies
in the Global Steel industry.

( Industry Median: 0.54 vs. MT: 0.39 )
Ranked among companies with meaningful PS Ratio only.
MT' s PS Ratio Range Over the Past 10 Years
Min: 0.07  Med: 0.29 Max: 1
Current: 0.39
0.07
1
Price-to-Operating-Cash-Flow 10.96
MT's Price-to-Operating-Cash-Flow is ranked lower than
73% of the 247 Companies
in the Global Steel industry.

( Industry Median: 6.94 vs. MT: 10.96 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MT' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.75  Med: 5.69 Max: 16.77
Current: 10.96
1.75
16.77
EV-to-EBIT 10.63
MT's EV-to-EBIT is ranked higher than
78% of the 537 Companies
in the Global Steel industry.

( Industry Median: 14.04 vs. MT: 10.63 )
Ranked among companies with meaningful EV-to-EBIT only.
MT' s EV-to-EBIT Range Over the Past 10 Years
Min: -1341.1  Med: 8 Max: 57.9
Current: 10.63
-1341.1
57.9
EV-to-EBITDA 6.20
MT's EV-to-EBITDA is ranked higher than
86% of the 582 Companies
in the Global Steel industry.

( Industry Median: 11.07 vs. MT: 6.20 )
Ranked among companies with meaningful EV-to-EBITDA only.
MT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -63  Med: 6.9 Max: 63.2
Current: 6.2
-63
63.2
Shiller PE Ratio 18.24
MT's Shiller PE Ratio is ranked higher than
57% of the 76 Companies
in the Global Steel industry.

( Industry Median: 19.66 vs. MT: 18.24 )
Ranked among companies with meaningful Shiller PE Ratio only.
MT' s Shiller PE Ratio Range Over the Past 10 Years
Min: 2.5  Med: 5.19 Max: 22.33
Current: 18.24
2.5
22.33
Current Ratio 1.23
MT's Current Ratio is ranked lower than
63% of the 442 Companies
in the Global Steel industry.

( Industry Median: 1.51 vs. MT: 1.23 )
Ranked among companies with meaningful Current Ratio only.
MT' s Current Ratio Range Over the Past 10 Years
Min: 1.06  Med: 1.4 Max: 2.03
Current: 1.23
1.06
2.03
Quick Ratio 0.41
MT's Quick Ratio is ranked lower than
84% of the 442 Companies
in the Global Steel industry.

( Industry Median: 0.99 vs. MT: 0.41 )
Ranked among companies with meaningful Quick Ratio only.
MT' s Quick Ratio Range Over the Past 10 Years
Min: 0.41  Med: 0.66 Max: 1.32
Current: 0.41
0.41
1.32
Days Sales Outstanding 19.99
MT's Days Sales Outstanding is ranked higher than
83% of the 433 Companies
in the Global Steel industry.

( Industry Median: 59.28 vs. MT: 19.99 )
Ranked among companies with meaningful Days Sales Outstanding only.
MT' s Days Sales Outstanding Range Over the Past 10 Years
Min: 15.38  Med: 22.25 Max: 34.39
Current: 19.99
15.38
34.39

Buy Back

vs
industry
vs
history
3-Year Dividend Growth Rate -100.00
MT's 3-Year Dividend Growth Rate is ranked lower than
76% of the 244 Companies
in the Global Steel industry.

( Industry Median: -3.90 vs. MT: -100.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
MT' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 8.5
Current: -100
0
8.5
5-Year Yield-on-Cost % 0.72
MT's 5-Year Yield-on-Cost % is ranked lower than
73% of the 611 Companies
in the Global Steel industry.

( Industry Median: 2.08 vs. MT: 0.72 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
MT' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.11  Med: 0.52 Max: 1.47
Current: 0.72
0.11
1.47
3-Year Average Share Buyback Ratio -7.70
MT's 3-Year Average Share Buyback Ratio is ranked lower than
71% of the 227 Companies
in the Global Steel industry.

( Industry Median: -1.70 vs. MT: -7.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MT' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -125.3  Med: -5.4 Max: 1.4
Current: -7.7
-125.3
1.4

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 1.04
MT's Price-to-Tangible-Book is ranked higher than
54% of the 495 Companies
in the Global Steel industry.

( Industry Median: 1.08 vs. MT: 1.04 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
MT' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.36  Med: 0.72 Max: 2.33
Current: 1.04
0.36
2.33
Price-to-Intrinsic-Value-Projected-FCF 1.06
MT's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
57% of the 256 Companies
in the Global Steel industry.

( Industry Median: 0.85 vs. MT: 1.06 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MT' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.28  Med: 0.52 Max: 3.13
Current: 1.06
0.28
3.13
Price-to-Median-PS-Value 1.35
MT's Price-to-Median-PS-Value is ranked higher than
51% of the 495 Companies
in the Global Steel industry.

( Industry Median: 1.33 vs. MT: 1.35 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MT' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.32  Med: 1.06 Max: 3.17
Current: 1.35
0.32
3.17
Price-to-Graham-Number 0.79
MT's Price-to-Graham-Number is ranked higher than
58% of the 289 Companies
in the Global Steel industry.

( Industry Median: 0.83 vs. MT: 0.79 )
Ranked among companies with meaningful Price-to-Graham-Number only.
MT' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.3  Med: 0.79 Max: 4.13
Current: 0.79
0.3
4.13
Earnings Yield (Greenblatt) % 9.41
MT's Earnings Yield (Greenblatt) % is ranked higher than
83% of the 694 Companies
in the Global Steel industry.

( Industry Median: 4.90 vs. MT: 9.41 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MT' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.7  Med: 8.2 Max: 32.3
Current: 9.41
1.7
32.3
Forward Rate of Return (Yacktman) % 3.63
MT's Forward Rate of Return (Yacktman) % is ranked higher than
58% of the 289 Companies
in the Global Steel industry.

( Industry Median: -1.52 vs. MT: 3.63 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MT' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -23.6  Med: 11.3 Max: 38.1
Current: 3.63
-23.6
38.1

More Statistics

Revenue (TTM) (Mil) $56,791
EPS (TTM) $ 0.64
Beta2.87
Short Percentage of Float0.99%
52-Week Range $4.18 - 9.37
Shares Outstanding (Mil)3,065.71

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 65,069 61,658 62,831
EPS ($) 0.94 0.84 0.97
EPS without NRI ($) 0.94 0.84 0.97
EPS Growth Rate
(Future 3Y To 5Y Estimate)
-26.65%
Dividends per Share ($) 0.14 0.28 0.37
» More Articles for MT

Headlines

Articles On GuruFocus.com
7 Stocks Outperforming the Market Jan 24 2017 
Causeway International Value’s Top 3 New Holdings Dec 09 2016 
3 Top Stocks to Play in New Presidency Nov 23 2016 
Mettrum Announces Fourth Quarter and Full Fiscal Year 2016 Financial Results Jun 29 2016 
Mettrum Announces Fourth Quarter and Full Fiscal Year 2016 Financial Results Notification Jun 22 2016 
Mettrum Receives License Amendment for the Sale of Medical Cannabis and Extracts at its 60,000 Squar May 09 2016 
Former Bestinver Executives' New Fund Lists 4 Top Undervalued Holdings Apr 05 2016 
Mettrum Announces Stock Options Grant Mar 03 2016 
Mettrum Announces Third Quarter Fiscal 2016 Financial Results Feb 23 2016 
Mettrum Receives Health Canada License to Sell Cannabis Extracts Dec 24 2015 

More From Other Websites
Why Steel Is a Top Stock Industry for Investors Right Now Apr 24 2017
Blog Coverage: UK's Liberty House Plans to Takeover ArcelorMittal's Georgetown Steelworks Plant Apr 24 2017
Steel Rallies on Trump Memo, but Our Outlook Is Still Negative Apr 24 2017
Overseas Earnings Estimated to Outdo US: Top 5 Gainers Apr 20 2017
U.S. Steel’s 2017 Guidance: What Investors Should Expect Apr 19 2017
1Q17 Preview: Can U.S. Steel Generate Free Cash Flow? Apr 19 2017
U.S. Steel’s 1Q17 Revenue: What’s the Word on Wall Street? Apr 18 2017
A Steel Glut Is Killing This Commodity and Taking Some Stocks With It Apr 18 2017
Disgruntled French steel workers turn to populist Le Pen Apr 18 2017
Stocks That Are Changing Direction Apr 17 2017
Top Ranked Value Stocks to Buy for April 17th Apr 17 2017
What Could Be the Key Drivers of AK Steel’s 1Q17 Profitability? Apr 17 2017
Post Earnings Coverage as Schnitzer Steel's Q2 Top-line Surged 32% y-o-y Apr 17 2017
AK Steel’s 1Q17 Earnings: What’s the Word on Wall Street? Apr 17 2017
Here’s Why Nucor’s Profits Are Expected to Surge in 1Q17 Apr 14 2017
Cliffs Natural Resources and ArcelorMittal Looking for an Industry Sized Lamp Apr 13 2017
Why is P/B Ratio a Great Valuation Metric? Apr 12 2017
Will ArcelorMittal Continue to Ride High? Apr 12 2017
Analysts Might Take a Fresh Look at U.S. Steel Corporation Apr 11 2017
How Do Analysts Rate Nucor This Earnings Season? Apr 10 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)